Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 69 publications
PSMA PET/CT-derived Tumor Volume for Predicting Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving 177Lu-PSMA-617.
Journal: Radiology
Published: March 31, 2026
Industry-Academic Collaboration in Nuclear Medicine: Proceedings from the 2024 CMIIT Industry Partners Circle.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: March 25, 2026
CD8 PET imaging with [89Zr]Zr-berdoxam-crefmirlimab in patients with solid tumors: the Phase II iCorrelate study.
Journal: Journal for immunotherapy of cancer
Published: March 13, 2026
Clinical Trial Protocol for LPS-Boost: Intensified [177Lu]Lu-PSMA-617 Treatment for Patients with Metastatic Castration-Resistant Prostate Cancer with Low PSMA-Expressing Disease.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: March 08, 2026
Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group 4.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 26, 2026
Deep learning-based non-invasive profiling of tumor transcriptomes from cell-free DNA for precision oncology.
Journal: bioRxiv : the preprint server for biology
Published: February 23, 2026
Prognostic Value of Cycle 1 SPECT SUVmean in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with 177Lu-PSMA-617.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: October 30, 2025
Results from a prospective registry of 18F-Fluciclovine PET/CT use in prostate cancer management: a cautionary lesson for implementation of PSMA PET.
Journal: American journal of nuclear medicine and molecular imaging
Published: June 23, 2025
Gallbladder Neuroendocrine Tumor and 177 Lu DOTATATE: High Somatostatin Receptor Expression Without Clinical Response.
Journal: Clinical nuclear medicine
Published: March 11, 2025
[18 F]-Fluoroestradiol PET (FES-PET) and [18 F] Flurodeoxyglucose PET (FDG-PET) Imaging May Aid in Managing Therapy in Patients with Metastatic Lobular Breast Cancer.
Journal: Molecular imaging and biology
Published: February 18, 2025
Artificial Intelligence for Drug Discovery: An Update and Future Prospects.
Journal: Seminars in nuclear medicine
Published: January 15, 2025
The Role of SPECT/CT in 177 Lu-PSMA-617 Theranostics: Case-based Review of Response and Progression Patterns.
Journal: Clinical nuclear medicine
Published: November 18, 2024
Last Updated: 09/26/2026